BIO
Bio-Rad Laboratories, Inc. · Healthcare · Medical - Devices
Señales de momentum (gestores comparables):
amplitud de titulares +11.1% ·
flujo de acciones -3.6% ·
nuevas posiciones netas +5.0%
· fórmula
Fragmentación de la titularidad: más titulares, participación agregada más pequeña
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 149.14K | $56.30M | n/a | −1 |
| Q2 2026 | 114 | -3 | 11.65M | $3.42B | +7 | −12 |
| Q1 2026 | 122 | +9 | 14.35M | $4.00B | +14 | −6 |
| Q4 2025 | 113 | -3 | 13.80M | $4.16B | +1 | −3 |
| Q3 2025 | 20 | +2 | 5.24M | $1.47B | +2 | −1 |
| Q2 2025 | 16 | -1 | 5.26M | $1.27B | +1 | −2 |
| Q1 2025 | 14 | -2 | 1.87M | $455.90M | n/a | −2 |
| Q4 2024 | 16 | +1 | 2.05M | $672.31M | +1 | n/a |
| Q3 2024 | 14 | +2 | 1.60M | $536.26M | +3 | −1 |
| Q2 2024 | 12 | n/a | 1.03M | $281.62M | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (pasivo) | 1.79M | -2.9% | $502.89M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 2 | BlackRock ✦ (pasivo) | 1.70M | -3.8% | $475.50M | 0.0% | ▼ Trim | 2 | SEC ↗ ×17 |
| 3 | State Street Global Advisors ✦ (pasivo) | 571.60K | -2.2% | $160.27M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 4 | Geode Capital Management ✦ (pasivo) | 350.22K | +4.8% | $98.21M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 5 | Morgan Stanley ✦ | 174.06K | n/a | $48.81M | 0.0% | n/c | 1 | SEC ↗ ×13 |
| 6 | Fisher Asset Management ✦ | 133.47K | -3.1% | $37.42M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 7 | Gotham Asset Management ✦ | 124.63K | +41.8% | $34.94M | 0.2% | ▲ Add | 6 | SEC ↗ |
| 8 | JPMorgan Chase ✦ | 112.50K | n/a | $31.54M | 0.0% | n/c | 1 | SEC ↗ ×12 |
| 9 | T. Rowe Price ✦ | 75.48K | +105.0% | $21.16M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 10 | Citadel Advisors ✦ | 50.31K | +1821.5% | $14.11M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 11 | AQR Capital Management ✦ | 31.97K | +13.4% | $8.73M | 0.0% | ▲ Add | 6 | SEC ↗ ×5 |
| 12 | GAMCO Investors ✦ | 26.75K | 0.0% | $7.50M | 0.1% | Held | 6 | SEC ↗ |
| 13 | Millennium Management ✦ | 24.45K | -90.3% | $6.86M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 14 | Goldman Sachs Group ✦ | 20.31K | n/a | $5.70M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 15 | Arrowstreet Capital ✦ | 13.71K | -42.8% | $3.84M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | Marshall Wace ✦ | 12.61K | +1262.2% | $3.54M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 17 | Bridgewater Associates ✦ | 10.63K | Nuevo | $2.98M | 0.0% | New | 1 | SEC ↗ |
| 18 | Point72 Asset Management ✦ | 10.20K | Nuevo | $2.86M | 0.0% | New | 1 | SEC ↗ |
| 19 | D. E. Shaw & Co. ✦ | 3.30K | 0.0% | $925,287 | 0.0% | Held | 6 | SEC ↗ |
| 20 | Fidelity (FMR) ✦ | 2.92K | +28.1% | $817,539 | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Bridgewater Associates | $2.98M | 0.0% |
| Point72 Asset Management | $2.86M | 0.0% |
Posición cerrada
| Norges Bank | $30.99M | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 387 tenedores, 19.87M acciones, $5.29B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.